In summary, for the first time, our study has identified the contribution of the USP21/YY1/SNHG16/miR-4500 axis in NSCLC, which might provide therapeutic strategies for the treatment of NSCLC. The gene discussed is YY1; the disease is non-small cell lung carcinoma.